Abstract:The major targets of current drugs used in mental health, such as neurotransmitter receptors and transporters, are based on serendipitous findings from several decades ago, and there is currently a severe drought of new drug targets. There is a pressing need for novel drugs, and much hope has been placed on the use of molecular genetics to help define them. However, despite evidence for a genetic basis to schizophrenia stretching back for over a century, and a heritability of about 80%, the identification of susceptibility genes has been an uphill struggle. Candidate gene studies, which have generally focussed on obvious candidates from the dopamine and serotonin systems, as well as genes involved in brain development, have not generally been successful, although meta-analysis indicates that the dopamine D3 receptor gene (DRD3) and the serotonin receptor gene type 2A (HTR2A) may have a very small influence on risk. Linkage analysis has provided robust evidence of genetic loci, for example, on chromosomes 8p, 13q and 22q, and also implies shared genetic aetiology with bipolar disorder. The identification of these loci together with advances in genetic technology, especially the characterisation of polymorphisms, the understanding of haplotypes and the development of statistical methods, has lead to the identification of several plausible susceptibility genes, including neuregulin 1, proline dehydrogenase and dysbindin. Interestingly, these genes point more towards a role for the glutamate pathway rather than the dopamine pathway in schizophrenia. We have attempted to replicate some of these findings in schizophrenic patients from SW China, and we find significant association with a novel neuregulin 1 haplotype, with proline dehydrogenase polymorphisms, but not with catechol-O-methyltransferase (COMT). The replication of neuregulin 1 association on chromosome 8p by several investigators is the most convincing to date, and the presence of a syndrome similar to dementia praecox of 8p linked families, and the lack of linkage of bipolar disorder to this region is a testament to the ideas of Kraepelin more than 100 years ago.

Mapping of the Mouse Glutamate Receptor δ1Subunit (Grid1) to Chromosome 14

Significant Linkage and Association Between a Functional (gt)n Polymorphism in Promoter of the N-methyl-D-aspartate Receptor Subunit Gene (GRIN2A) and Schizophrenia.

The genetics of schizophrenia: glutamate not dopamine?

[Linkage Analysis of Susceptibility Genes for Familial Schizophrenia on Chromosome 1 in Chinese Population].

Meta-Analysis of Genome Wide Association Studies Showed Polymorphisms on 2P16.1, 6P22.1 and 10Q24.32 Associated with Schizophrenia in Chinese Han Population

Whole-genome Sequencing of Monozygotic Twins Discordant for Schizophrenia Indicates Multiple Genetic Risk Factors for Schizophrenia.

Cross-disorder Genomewide Analysis of Schizophrenia, Bipolar Disorder, and Depression.

[Genome-wide linkage scan for an ethnic Han Chinese pedigree affected with schizophrenia].

Genome-wide approaches to schizophrenia

Identification of a Risk Locus at 7p22.3 for Schizophrenia and Bipolar Disorder in East Asian Populations

Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia

Common genetic variants shared among five major psychiatric disorders: a large-scale genome-wide combined analysis

Fine-mapping genomic loci refines bipolar disorder risk genes

Genome-wide Scans of Three Independent Sets of 90 Irish Multiplex Schizophrenia Families and Follow-Up of Selected Regions in All Families Provides Evidence for Multiple Susceptibility Genes

Impact of a Cis-Associated Gene Expression SNP on Chromosome 20q11.22 on Bipolar Disorder Susceptibility, Hippocampal Structure and Cognitive Performance.

A Genome-wide Association Analysis of a Broad Psychosis Phenotype Identifies Three Loci for Further Investigation

Identification of Candidate Genes for Psychiatric Disorders on 18P11

Genetic associations between bipolar disorder and brain structural phenotypes

Novel genetic susceptibility loci identified by family based whole exome sequencing in Han Chinese schizophrenia patients

Identifying Common Genome-Wide Risk Genes for Major Psychiatric Traits

A Case-Control Association Study Between the Grid1 Gene and Schizophrenia in the Chinese Northern Han Population